These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31358774)
1. Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD. Nishimoto M; Uranishi K; Asaka MN; Suzuki A; Mizuno Y; Hirasaki M; Okuda A Sci Rep; 2019 Jul; 9(1):10933. PubMed ID: 31358774 [TBL] [Abstract][Full Text] [Related]
2. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity. Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865 [TBL] [Abstract][Full Text] [Related]
3. TEAD mediates YAP-dependent gene induction and growth control. Zhao B; Ye X; Yu J; Li L; Li W; Li S; Yu J; Lin JD; Wang CY; Chinnaiyan AM; Lai ZC; Guan KL Genes Dev; 2008 Jul; 22(14):1962-71. PubMed ID: 18579750 [TBL] [Abstract][Full Text] [Related]
4. Cell competition in mouse NIH3T3 embryonic fibroblasts is controlled by the activity of Tead family proteins and Myc. Mamada H; Sato T; Ota M; Sasaki H J Cell Sci; 2015 Feb; 128(4):790-803. PubMed ID: 25588835 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional integration of mitogenic and mechanical signals by Myc and YAP. Croci O; De Fazio S; Biagioni F; Donato E; Caganova M; Curti L; Doni M; Sberna S; Aldeghi D; Biancotto C; Verrecchia A; Olivero D; Amati B; Campaner S Genes Dev; 2017 Oct; 31(20):2017-2022. PubMed ID: 29141911 [TBL] [Abstract][Full Text] [Related]
6. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Zhao B; Kim J; Ye X; Lai ZC; Guan KL Cancer Res; 2009 Feb; 69(3):1089-98. PubMed ID: 19141641 [TBL] [Abstract][Full Text] [Related]
7. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Ota M; Sasaki H Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856 [TBL] [Abstract][Full Text] [Related]
8. Serum Inter-α-inhibitor activates the Yes tyrosine kinase and YAP/TEAD transcriptional complex in mouse embryonic stem cells. Pijuan-Galitó S; Tamm C; Annerén C J Biol Chem; 2014 Nov; 289(48):33492-502. PubMed ID: 25301940 [TBL] [Abstract][Full Text] [Related]
9. Organ of Corti size is governed by Yap/Tead-mediated progenitor self-renewal. Gnedeva K; Wang X; McGovern MM; Barton M; Tao L; Trecek T; Monroe TO; Llamas J; Makmura W; Martin JF; Groves AK; Warchol M; Segil N Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13552-13561. PubMed ID: 32482884 [TBL] [Abstract][Full Text] [Related]
10. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Liu-Chittenden Y; Huang B; Shim JS; Chen Q; Lee SJ; Anders RA; Liu JO; Pan D Genes Dev; 2012 Jun; 26(12):1300-5. PubMed ID: 22677547 [TBL] [Abstract][Full Text] [Related]
11. c-Abl antagonizes the YAP oncogenic function. Keshet R; Adler J; Ricardo Lax I; Shanzer M; Porat Z; Reuven N; Shaul Y Cell Death Differ; 2015 Jun; 22(6):935-45. PubMed ID: 25361080 [TBL] [Abstract][Full Text] [Related]
12. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Vassilev A; Kaneko KJ; Shu H; Zhao Y; DePamphilis ML Genes Dev; 2001 May; 15(10):1229-41. PubMed ID: 11358867 [TBL] [Abstract][Full Text] [Related]
13. YAP/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner. Han D; Byun SH; Park S; Kim J; Kim I; Ha S; Kwon M; Yoon K Biochem Biophys Res Commun; 2015 Feb; 458(1):110-6. PubMed ID: 25634692 [TBL] [Abstract][Full Text] [Related]
14. Mutual dependence of the MRTF-SRF and YAP-TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics. Foster CT; Gualdrini F; Treisman R Genes Dev; 2017 Dec; 31(23-24):2361-2375. PubMed ID: 29317486 [TBL] [Abstract][Full Text] [Related]
15. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335 [TBL] [Abstract][Full Text] [Related]
16. Epiblast Formation by TEAD-YAP-Dependent Expression of Pluripotency Factors and Competitive Elimination of Unspecified Cells. Hashimoto M; Sasaki H Dev Cell; 2019 Jul; 50(2):139-154.e5. PubMed ID: 31204175 [TBL] [Abstract][Full Text] [Related]
17. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition. Diepenbruck M; Waldmeier L; Ivanek R; Berninger P; Arnold P; van Nimwegen E; Christofori G J Cell Sci; 2014 Apr; 127(Pt 7):1523-36. PubMed ID: 24554433 [TBL] [Abstract][Full Text] [Related]
18. Blockage of glioma cell survival by truncated TEAD-binding domain of YAP. Zhao W; Dong QF; Li LW; Yan ZF; Huo JL; Chen XY; Yang X; Li PQ; Fei Z; Zhen HN J Cancer Res Clin Oncol; 2021 Jun; 147(6):1713-1723. PubMed ID: 33651140 [TBL] [Abstract][Full Text] [Related]
19. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis. Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715 [TBL] [Abstract][Full Text] [Related]
20. Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation. Mathiasen DP; Egebjerg C; Andersen SH; Rafn B; Puustinen P; Khanna A; Daugaard M; Valo E; Tuomela S; Bøttzauw T; Nielsen CF; Willumsen BM; Hautaniemi S; Lahesmaa R; Westermarck J; Jäättelä M; Kallunki T Oncogene; 2012 Jan; 31(3):390-401. PubMed ID: 21706057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]